Hybridomics

Hybridomics is one of the world's largest holders of hybridoma clones to monoclonal antibodies. With over 6,000 clones in our portfolio, we are the original creators and manufacturers of mouse and rabbit hybridomas. Many of our products are also available as recombinants. Our products focus on the Immunohistochemistry and Immuno-oncology markets and are well validated for IHC, Western Blotting, and Flow Cytometry applications. We out-license our clones for use in kits and immunoassays and in-license other clones of clinical interest. Our antibody products are supplied through NeoBiotechnologies. (www.neobiotechnologies.com)

所属行业

生物技术研究

规模

11-50 人

总部

Union City，California

类型

私人持股

创立

2013

领域

hybridomas、hybridoma clones、antibodies、cell lines、rabbit antibodies、immunoassays、ELISA kits、biological reagents、monoclonal antibodies、research、drug discovery、diagnostics、RabMAb、Life Sciences、Cancer diagnostics、Immunohistochemistry (IHC)、Flow Cytometry、immuno-oncology和recombinant antibodies